[HTML][HTML] Comprehensive research on past and future therapeutic strategies devoted to treatment of amyotrophic lateral sclerosis

B Sever, H Ciftci, H DeMirci, H Sever, F Ocak… - International journal of …, 2022 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a rapidly debilitating fatal neurodegenerative disorder,
causing muscle atrophy and weakness, which leads to paralysis and eventual death. ALS …

[HTML][HTML] Where and why modeling amyotrophic lateral sclerosis

F Liguori, S Amadio, C Volonté - International Journal of Molecular …, 2021 - mdpi.com
Over the years, researchers have leveraged a host of different in vivo models in order to
dissect amyotrophic lateral sclerosis (ALS), a neurodegenerative/neuroinflammatory …

[HTML][HTML] Defective oligodendroglial lineage and demyelination in amyotrophic lateral sclerosis

E Traiffort, S Morisset-Lopez, M Moussaed… - International journal of …, 2021 - mdpi.com
Motor neurons and their axons reaching the skeletal muscle have long been considered as
the best characterized targets of the degenerative process observed in amyotrophic lateral …

[HTML][HTML] Harnessing the potential of human pluripotent stem cell-derived motor neurons for drug discovery in amyotrophic lateral sclerosis: from the clinic to the …

NJ Lamas, L Roybon - Frontiers in Drug Discovery, 2021 - frontiersin.org
Amyotrophic Lateral Sclerosis (ALS) is a motor neurodegenerative disorder whose cellular
hallmarks are the progressive death of motor neurons (MNs) located in the anterior horn of …

Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis

MF Elmansy, CT Reidl, M Rahaman… - Medicinal Research …, 2023 - Wiley Online Library
Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease in which the
motor neuron circuitry displays progressive degeneration, affecting mostly the motor …

[HTML][HTML] Human IL12p80 promotes murine oligodendrocyte differentiation to repair nerve injury

YF Chung, JH Chen, CW Li, HY Hsu, YP Chen… - International Journal of …, 2022 - mdpi.com
Nerve injury of the central nervous system and the peripheral nervous system still poses a
major challenge in modern clinics. Understanding the roles of neurotrophic factors and their …

Synaptic transmission and Motoneuron excitability defects in amyotrophic lateral sclerosis

F Scamps, F Aimond, C Hilaire, C Raoul - Exon Publications, 2021 - exonpublications.com
Amyotrophic lateral sclerosis is a fatal adult-onset neurodegenerative disease characterized
by progressive muscular weakness and atrophy. The primary feature of amyotrophic lateral …

PROTACs for TDP-43 Degradation: A Viable Therapeutic Strategy for ALS

S Zhang - 2024 - figshare.mq.edu.au
Amyotrophic lateral sclerosis (ALS) is a cruel neurodegenerative disease resulting in
eventual paralysis, respiratory dysfunction, and death, typically within 2-4 years from …

Gene editing hPSCs for modeling neurological disorders

A Petersen - Phenotyping of Human iPSC-derived Neurons, 2023 - Elsevier
The promise of pluripotent stem cell (PSC)-based neuronal models and therapeutic
solutions is dependent upon how well they replicate in vivo phenotypes and function …

[PDF][PDF] AMYOTROPHIC LATERAL SCLEROSIS: RAPIDLY ACCELERATING COMPLEX NEURO-DEGENERATIVE DISEASE

A Arya, P Tyagi, S Yadav, R Kadian - researchgate.net
An amyotrophic lateral sclerosis is a group of progressive neurodegenerative disorders of
motor neurons that leads to weakness, muscle atrophy, progressive paralysis, and …